Zur Kurzanzeige

dc.contributor.authorGarcía Domingo, Mónica 
dc.contributor.authorMorán Benito, Asunción 
dc.contributor.authorMartín Calvo, María Luisa 
dc.contributor.authorBarthelmebs, Mariette
dc.contributor.authorSan Román, Luis
dc.date.accessioned2024-07-31T11:26:52Z
dc.date.available2024-07-31T11:26:52Z
dc.date.issued2006-05-10
dc.identifier.citationGarcía, M., Morán, A., Martín, M. L., Barthelmebs, M., & San Román, L. (2006). The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. European journal of pharmacology, 537(1-3), 126-134.es_ES
dc.identifier.issn0014-2999
dc.identifier.urihttp://hdl.handle.net/10366/159278
dc.description.abstract[EN]We investigated the involvement of the nitric oxide pathway in the inhibitory mechanisms of 5-hydroxytryptamine (5-HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in diabetic pithed rats. Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan. Four weeks later, the animals were anaesthetized, pretreated with atropine, and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency-dependent increases in blood pressure. The inhibition of electrically induced pressor responses by 5-HT (10 microg/kg/min) in diabetic pithed rats could not be elicited after i.v. treatment with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 microg/kg), a guanylyl cyclase inhibitor, or N-omega-L-Arginine methyl ester hydrochloride (L-NAME) (10 mg/kg), a nitric oxide synthase (NOS) inhibitor. The inhibitory effect produced by infusion of the selective 5-HT(1A) receptor agonist 8-hydroxydipropylaminotretalin hydrobromide (8-OH-DPAT) (20 microg/kg/min) was abolished in the presence of ODQ (10 microg/kg), or L-NAME (10 mg/kg) in diabetic pithed rats. The administration of L-Arginine (100 mg/kg) 30 min after L-NAME reproduced the inhibitory effect caused by 5-HT (10 microg/kg/min) and 8-OH-DPAT (20 microg/kg/min) on the electrically induced pressor responses, whereas in the presence of D-Arginine (100 mg/kg)+L-NAME the 5-HT or 8-OH-DPAT inhibitory effect on the pressor responses was abolished. In conclusion, in diabetic pithed rats, the inhibition produced by prejunctional 5-HT(1A) activation on electrically induced sympathetic pressor responses is mediated by the NO synthesis/pathway.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.subject5-hydroxytryptaminees_ES
dc.subjectNitric oxidees_ES
dc.subjectExperimental diabeteses_ES
dc.subject5-HT1A receptorses_ES
dc.subjectPrejunctional inhibitiones_ES
dc.subject.meshNG-Nitroarginine Methyl Ester *
dc.subject.meshNitric Oxide Synthase *
dc.subject.meshDiabetes Mellitus *
dc.subject.meshElectric Stimulation *
dc.subject.mesh8-Hydroxy-2-(di-n-propylamino)tetralin *
dc.subject.meshAtropine *
dc.subject.meshNorepinephrine *
dc.subject.meshNitric Oxide *
dc.subject.meshBlood Pressure *
dc.subject.meshOxadiazoles *
dc.subject.meshSerotonin *
dc.subject.meshEnzyme Inhibitors *
dc.subject.meshQuinoxalines *
dc.subject.meshSpinal Cord *
dc.subject.meshMuscarinic Antagonists *
dc.subject.meshGuanylate Cyclase *
dc.subject.meshRats *
dc.subject.meshAnimals *
dc.subject.meshSerotonin 5-HT1 Receptor Agonists *
dc.subject.meshVasoconstriction *
dc.subject.meshTryptamines *
dc.subject.meshSerotonin Receptor Agonists *
dc.titleThe nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/j.ejphar.2006.03.020es_ES
dc.subject.unesco3209 Farmacologíaes_ES
dc.identifier.doi10.1016/j.ejphar.2006.03.020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid16630608
dc.journal.titleEuropean Journal of Pharmacologyes_ES
dc.volume.number537es_ES
dc.issue.number1-3es_ES
dc.page.initial126es_ES
dc.page.final134es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsvasoconstricción *
dc.subject.decsinhibidores enzimáticos *
dc.subject.decsóxido nítrico *
dc.subject.decsestimulación eléctrica *
dc.subject.decsguanilato ciclasa *
dc.subject.decsagonistas de receptores de serotonina 5-HT1 *
dc.subject.decsNG-nitroarginina metil éster *
dc.subject.decsserotonina *
dc.subject.decsnorepinefrina *
dc.subject.decsatropina *
dc.subject.decspresión sanguínea *
dc.subject.decsóxido nítrico sintasa *
dc.subject.decstriptaminas *
dc.subject.decsanimales *
dc.subject.decs8-hidroxi-2-(di-n-propilamino)tetralina *
dc.subject.decsagonistas de receptores de serotonina *
dc.subject.decsmédula espinal *
dc.subject.decsratas *
dc.subject.decsdiabetes mellitus *
dc.subject.decsoxadiazoles *
dc.subject.decsquinoxalinas *
dc.subject.decsantagonistas muscarínicos *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige